"Our unique understanding of cancer stem cell biology, and diligent execution by our research and development team, has allowed us to build a leading portfolio of cancer stem cell targeting agents" Research by the company and Robert Weinberg, Ph.D., Verastem co-founder and chair of the Scientific Advisory Board, has demonstrated in preclinical ... (more)
http://www.drugs.com/news/verastem-initiates-phase-1-clinical-trial-vs-4718-patients-advanced-cancer-45574.html?
http://www.drugs.com/news/verastem-initiates-phase-1-clinical-trial-vs-4718-patients-advanced-cancer-45574.html?
No comments:
Post a Comment